This study describes a method for the screening of methylenedioxyamphetamine- and piperazine-derived compounds in urine by liquid chromatography-tandem mass spectrometry. These substances, characterized by possessing common moieties, are screened using precursor ion and neutral loss scan mode and then quantified in multiple reaction monitoring acquisition mode. Based on the product-ion spectra of different known molecules, chosen as model, characteristic neutral losses and product ions were selected: piperazines were detected in precursor ion scan of m/z 44 and neutral loss of 43 and 86 while amphetamines in precursor ion scan of m/z 133, 135 and 163. The applicability of the screening approach was studied in blank urine spiked with selected analytes and processed by solid-phase extraction. Linearity, matrix effect, precision, accuracy, limits of detection and limits of quantification were evaluated both for the screening and the quantification methods. The ability of the screening method to provide semi-quantitative data was demonstrated. This method appears to be a useful tool for the identification of designer drugs derived from piperazines or methylenedioxyamphetamines and can be potentially applied to other drug classes.

(2013). Screening of methylenedioxyamphetamine- and piperazine-derived designer drugs in urine by LC-MS/MS using neutral loss and precursor ion scan [journal article - articolo]. In JOURNAL OF MASS SPECTROMETRY. Retrieved from http://hdl.handle.net/10446/145554

Screening of methylenedioxyamphetamine- and piperazine-derived designer drugs in urine by LC-MS/MS using neutral loss and precursor ion scan

Romolo, Francesco Saverio;
2013-01-01

Abstract

This study describes a method for the screening of methylenedioxyamphetamine- and piperazine-derived compounds in urine by liquid chromatography-tandem mass spectrometry. These substances, characterized by possessing common moieties, are screened using precursor ion and neutral loss scan mode and then quantified in multiple reaction monitoring acquisition mode. Based on the product-ion spectra of different known molecules, chosen as model, characteristic neutral losses and product ions were selected: piperazines were detected in precursor ion scan of m/z 44 and neutral loss of 43 and 86 while amphetamines in precursor ion scan of m/z 133, 135 and 163. The applicability of the screening approach was studied in blank urine spiked with selected analytes and processed by solid-phase extraction. Linearity, matrix effect, precision, accuracy, limits of detection and limits of quantification were evaluated both for the screening and the quantification methods. The ability of the screening method to provide semi-quantitative data was demonstrated. This method appears to be a useful tool for the identification of designer drugs derived from piperazines or methylenedioxyamphetamines and can be potentially applied to other drug classes.
articolo
2013
Montesano, Camilla; Sergi, Manuel; Moro, Mariaelena; Napoletano, Sabino; Romolo, Francesco Saverio; Del Carlo, Michele; Compagnone, Dario; Curini, Rob...espandi
(2013). Screening of methylenedioxyamphetamine- and piperazine-derived designer drugs in urine by LC-MS/MS using neutral loss and precursor ion scan [journal article - articolo]. In JOURNAL OF MASS SPECTROMETRY. Retrieved from http://hdl.handle.net/10446/145554
File allegato/i alla scheda:
File Dimensione del file Formato  
Montesano_et_al-2013_Journal_of_Mass_Spectrometry.pdf

Solo gestori di archivio

Versione: publisher's version - versione editoriale
Licenza: Licenza default Aisberg
Dimensione del file 1.47 MB
Formato Adobe PDF
1.47 MB Adobe PDF   Visualizza/Apri
Pubblicazioni consigliate

Aisberg ©2008 Servizi bibliotecari, Università degli studi di Bergamo | Terms of use/Condizioni di utilizzo

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10446/145554
Citazioni
  • Scopus 26
  • ???jsp.display-item.citation.isi??? 24
social impact